Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Women gain stronger heart protection from exercise than men, study reveals

28

Oct 2025

Women gain stronger heart protection from exercise than men, study reveals

Researchers analyzing over 85,000 UK Biobank participants found that women gain greater cardiovascular benefits from physical activity than men, needing only half the exercise to achieve similar reductions in coronary heart disease and mortality risk. The study underscores the importance of sex-specific guidelines for CHD prevention.

First self-powered spinal implant can transmit real-time data from inside the body

28

Oct 2025

First self-powered spinal implant can transmit real-time data from inside the body

A collaboration between civil engineering and neurosurgery at the University of Pittsburgh could change how spinal fusion surgery is performed and monitored. Associate Professors Amir Alavi, Nitin Agarwal, and D. Kojo Hamilton have received a $352,213 National Institutes of Health (NIH) R21 grant to develop the first self-powered spinal implant capable of transmitting real-time data from inside the body.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.